肺炎支原体感染诱发儿童咳嗽变异性哮喘临床分析

目的分析由肺炎支原体感染诱发的咳嗽变异性哮喘的临床特点。方法对44例咳嗽变异性哮喘且肺炎支原体抗体阳性患儿回顾性分析，观察组23例，对照组21例，两组均给予了大环内酯类抗感染、止咳等治疗，观察组同时雾化吸入支气管扩张剂。结果肺炎支原体感染诱发的咳嗽变异性哮喘以咳嗽为主要症状，肺部未闻及哮鸣音，大环内酯类抗感染、止咳治疗无效，加以雾化吸入支气管扩张剂效果明显。结论肺炎支原体是诱发咳嗽变异性哮喘的重要因素之一，雾化吸入支气管扩张剂治疗效果显。

The clinical analysis of mycoplasma pneumonia induced cough variant asthma in children

Objective The purpose is to investigate the clinical characteristic of mycoplasma pneumonia infection induced cough variant asthma in children. Methods Analyze 44 cases with cough variant asthma and positive mycoplasma pneumonia antibody by serology retrospectively. They were divided into two groups. Both of them were given the treatment of macrolides and cough stopping. The study group also had bronchodilators nebulization. Results Cough is the cardinal symptom in the cases with mycoplasma pneumonia induced cough variant asthma. No wheezing rale in the lungs. The effect of macrolides and cough stopping was invalidation without bronchodilators nebulization. Conclusion Mycoplasma pneumonia may be one of the important factor induced cough variant asthma in children. Macrolides has significant therapeutic efficacy.